Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |